Craig shares how an unexpected diagnosis of osteonecrosis of the jaw led his healthcare team to stop Xgeva treatment, highlighting the importance of monitoring bone health, communicating new symptoms, and coordinating care between specialists during prostate cancer treatment.
Craig Deatherage:
And when we discovered the osteonecrosis, I was using an oncologist at the time to do that shot and I told his nurse about it when I went in for my monthly shot and she immediately took off into the doctor's office and came back out and said, "You're not doing these shots anymore. We have to stop these." And I had discovered that through the oral surgeon I was seeing because I was having bone health issues in my jaw.
I had not connected it to Xgeva, but the oral surgeon immediately connected it to Xgeva and said, "You need to get off this drug." And so when I went to my oncologist, fortunately that was only two days after I had seen my oral surgeon and they both were in complete agreement that this was not something I should continue. So that only happened just several months ago that I stopped the Xgeva. Still taking calcium for bone health, but I no longer take the Xgeva.